Evidence map›Paper›PMID 22542659›Full record

ArticleEuropean journal of pharmacology2012

Evidence for constitutively-active adenosine receptors at mammalian motor nerve endings.

Timothy J Searl, Eugene M Silinsky

Open access · greenAbstract read
In one paragraph

Article in European journal of pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Timothy J SearlDepartment of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, 303 East Chicago Avenue, Chicago, IL 60611, USA. tjs026@northwestern.edu
Eugene M Silinsky
Northwestern University · US

Funding

ADENOSINE DERIVATIVES AND TRANSMITTER RELEASER01NS012782 · NINDS · NORTHWESTERN UNIVERSITY · PI SILINSKY, EUGENE M · 1985 to 2003
$1.5M
Dissection of Ethanol Actions on Cholinergic Nerve EndingsR21AA016513 · NIAAA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SEARL, TIMOTHY · 2007 to 2008
$396k
NIAAA NIH HHS AA016513NIAAA NIH HHS R21 AA016513NINDS NIH HHS NS12782NINDS NIH HHS R01 NS012782
6 · The paper itself

Abstract

A study was made to determine if constitutively active adenosine receptors are present at mouse motor nerve endings. In preparations blocked by low Ca(2+)/high Mg(2+) solution, 8-cyclopentyl-1,3,dipropylxanthine (CPX, 10-100 nM), which has been reported to be both an A(1) adenosine receptor antagonist and inverse agonist, produced a dose-dependent increase in the number of acetylcholine quanta released by a nerve impulse. Adenosine deaminase, which degrades ambient adenosine into its inactive congener, inosine, failed to alter the response to 100 nM CPX. 8-Cyclopentyltheophylline (CPT, 3 μM), a competitive inhibitor at A(1) adenosine receptors, prevented the increase in acetylcholine release produced by CPX. At normal levels of acetylcholine release, neither adenosine deaminase nor CPX affected acetylcholine release at low frequencies of nerve stimulation in (+)-tubocurarine blocked preparations. The results suggest that a proportion of the acetylcholine release process is controlled by constitutively active adenosine receptors at murine motor nerve endings, providing the first evidence for constitutive activity of G-protein-coupled receptors that modulate the function of mammalian nerve endings.

Indexed as

AcetylcholineAdenosine A1 Receptor AntagonistsAdenosine DeaminaseAnimalsCalciumDose-Response Relationship, DrugDrug Inverse AgonismMagnesiumMiceMotor NeuronsNerve EndingsPurinergic P1 Receptor AntagonistsReceptors, Purinergic P1TheophyllineXanthines1,3-dipropyl-8-cyclopentylxanthine8-cyclopentyl-1,3-dimethylxanthineAcetylcholineAdenosine A1 Receptor AntagonistsAdenosine DeaminaseCalciumMagnesiumPurinergic P1 Receptor AntagonistsReceptors, Purinergic P1TheophyllineXanthines

Identifiers

PMID22542659
PMCPMC3358409
OpenAlexW2036647219

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.